Wnt family ligands

Wnt/β-catenin agonist 3 hydrochloride is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 (compound 98) can be used for the research of osteoporosis.Appearance:SolidIn Vitro:Wnt/β-catenin agonist 3 hydrochloride (compound 98 24

Wnt/β-catenin agonist 3 hydrochloride is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 (compound 98) can be used for the research of osteoporosis.Appearance:SolidIn Vitro:Wnt/β-catenin agonist 3 hydrochloride (compound 98 24

YAP-TEAD-IN-1 TFA is a potent and competitive peptide inhibitor of YAP-TEAD interaction ( IC 50 =25 nM). YAP-TEAD-IN-1 TFA is a 17mer peptide and shows a higher the binding affinity to TEAD1 ( K d =15 nM) than YAP (50-171) ( K d = 40 nM)In

YAP-TEAD-IN-1 TFA is a potent and competitive peptide inhibitor of YAP-TEAD interaction ( IC 50 =25 nM). YAP-TEAD-IN-1 TFA is a 17mer peptide and shows a higher the binding affinity to TEAD1 ( K d =15 nM) than YAP (50-171) ( K d = 40 nM)In

YAP-TEAD-IN-1 TFA is a potent and competitive peptide inhibitor of YAP-TEAD interaction ( IC 50 =25 nM). YAP-TEAD-IN-1 TFA is a 17mer peptide and shows a higher the binding affinity to TEAD1 ( K d =15 nM) than YAP (50-171) ( K d = 40 nM)In

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-1 is a YAP / TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC 50 of &lt0.100 μΜ in firefly luciferase assayIn VitroYAP and TAZ are transcriptional co-activators of the Hippo pathway network and regulate

YAP/TAZ inhibitor-2 is a potent and orally active TEAD-YAP/TAZ inhibitor with an EC 50 value of 3 nM. YAP/TAZ inhibitor-2 shows anti-proliferative activity. YAP/TAZ inhibitor-2 shows antitumor activityIn VitroYAP/TAZ inhibitor-2 (compound 5)